This scientific session focuses on novel experimental approaches and molecular insights into the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD), exploring potential therapeutic targets for its treatment.

The diagnosis and management of childhood liver disorders are undergoing rapid changes, aided by novel investigative approaches. In this session, attendees will learn from state-of-the-art clinical and translational studies advancing the field of pediatri

A broad examination of inflammatory mediators, mechanisms of inflammation and potential targeted strategies in liver disease driven by inflammation and inflammatory cells.

This session explores the intricate gut microbiota-liver crosstalk and its influence on liver disease progression, fibrosis and cirrhosis.